CDK4 and neutropenia: Patients with any grade neutropenia in the beginning of CDK4/6i treatment: C1D1, C1D14, or C2D1 had a higher risk of CDK4/6i dose reduction (p = 0.006; p < 0.0001; p < 0.0001, respectively).